Home > Blog > Nina Peterson

Nina Peterson, CANS

Nina Peterson is a Certified Aesthetic Nurse Specialist (CANS) specializing in facial contouring and non-surgical mini facelifts with PDO threads. With over nine years of experience gained in dermatology and plastic surgery practices, Nina also works as a medical blogger and consultant for aesthetic practices and licensed individuals, bringing her background in plastic surgery and dermatology to provide valuable insights.

author’s articles

A close-up shot of a medicine formulation during dilution.
How to Dilute Liporase – Step-by-Step Guidance

Recent advances in aesthetic medicine highlight the critical role of precise dilution when using hyaluronidase. A guidance document by King,...

Read More
An individual dealing with abdominal pain.
How Long Does Entyvio Take to Work?

A recent study published in the Journal of Crohn’s and Colitis analyzed data from 13,222 patients with inflammatory bowel disease...

Read More
Scientists working in a medical laboratory.
Entyvio Manufacturer – About Takeda Oncology

According to a recent study in BMC Public Health, approximately 405,000 new cases of inflammatory bowel disease (IBD) are diagnosed...

Read More
A close-up shot of a pregnant woman's belly.
Entyvio and Pregnancy – Is It Safe?

A 2023 narrative review in Reproductive Medicine revealed that pregnant individuals with active inflammatory bowel disease (IBD) face significantly higher...

Read More
An intravenous drip medication for infusion.
Entyvio Generic Name – About Vedolizumab

Recent systematic reviews indicate that vedolizumab, the generic name for Entyvio, significantly improves clinical outcomes in patients with inflammatory bowel...

Read More
An individual dealing with abdominal pain.
Entyvio for Crohn’s Disease – Is It Effective?

Nearly 790,000 Americans are estimated to live with Crohn’s disease, underscoring the significant public health challenge posed by this chronic...

Read More
A close-up shot of an IV drip infusion.
Entyvio Prescribing Information – Clinical Considerations for Physicians

A recent Phase 4 EARNEST study reported that vedolizumab induced clinical remission in 31% of patients by Week 14, compared...

Read More
A medical professional preparing an IV infusion treatment.
Entyvio Pen vs Infusion – How Do They Differ?

Clinical trials have demonstrated that biologic therapies like Entyvio (vedolizumab) can achieve remission rates of up to 47% by week...

Read More
An individual dealing with an inflammatory bowel disease.
Entyvio Mechanism of Action – How Does It Work?

A recent VARSITY study revealed that vedolizumab achieved an early clinical response in 67.1% of ulcerative colitis patients by week...

Read More
A close-up shot of an intravenous drip in a hospital.
Entyvio Dosing – Information for Practitioners

A 2020 study published in Frontiers in Pharmacology explored the variables to consider when prioritizing drugs for precision dosing, emphasizing...

Read More